CYCN (Cyclerion Therapeutics, Inc. Common Stock) Stock Analysis - Analyst Ratings

Cyclerion Therapeutics, Inc. Common Stock (CYCN) is a publicly traded Healthcare sector company. As of May 21, 2026, CYCN trades at $3.02 with a market cap of $13.08M and a P/E ratio of -2.27. CYCN moved +4.33% today. Year to date, CYCN is +123.19%; over the trailing twelve months it is -6.21%. Its 52-week range spans $1.03 to $9.47. Rallies surfaces CYCN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate CYCN?

The average price target is $0.00.

CYCN Key Metrics

Key financial metrics for CYCN
MetricValue
Price$3.02
Market Cap$13.08M
P/E Ratio-2.27
EPS$-1.36
Dividend Yield0.00%
52-Week High$9.47
52-Week Low$1.03
Volume42
Avg Volume0
Revenue (TTM)$1.99M
Net Income$-5.28M
Gross Margin0.00%

CYCN Analyst Consensus

CYCN analyst coverage data. Average price target: $0.00.

Latest CYCN News

Recent CYCN Insider Trades

  • Slate Path Capital LP sold 357.88K (~$555.11K) on Nov 21, 2024.
  • MCGUIRE TERRANCE sold 8 (~$27.16) on Aug 9, 2023.
  • MCGUIRE TERRANCE bought 92.83K (~$289.63K) on Jun 3, 2021.

Common questions about CYCN

What do analysts rate CYCN?
The average price target is $0.00.
Does Rallies show CYCN price targets?
Yes. Rallies tracks CYCN analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is CYCN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CYCN. It does not provide personalized investment advice.
CYCN

CYCN